{"id":217179,"date":"2026-08-24T15:10:17","date_gmt":"2026-08-24T09:40:17","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=217179"},"modified":"2026-08-24T15:10:19","modified_gmt":"2026-08-24T09:40:19","slug":"hospitals-stocks-flying-under-the-radar-india","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/","title":{"rendered":"5 Under the Radar Hospitals Stocks Flying Past the Usual Names in India"},"content":{"rendered":"<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>5 Hospitals stocks under the radar: CMP range Rs 335-1,360. Highest ROE 22.0% (Narayana). Lowest D\/E 0.10. Data: 23 August 2026.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0; color: #1f4e79; font-size: 14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin: 8px 0 0;\">The five hospital stocks that receive comparatively lower institutional coverage in India are HCG Oncology (Healthcare Global), Care Hospitals, Fortis Healthcare, Global Health (Medanta), and Narayana Hrudayalaya. These companies operate across key segments of the hospital sector with market caps ranging from Rs 3,550 crore to Rs 53,700 crore. Each carries specific financial characteristics worth evaluating independently. The data used in this article is based on publicly available NSE and BSE information as of 23 August 2026. This is a research shortlist, not a buy recommendation.<\/p>\n<\/div>\n<p>India offers far more hospital stocks than the three or four most-followed names in any given sector. This article identifies five hospital stocks that receive comparatively lower institutional research attention than the largest-cap peers. Each of these hospital stocks is evaluated on publicly available fundamental data.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=under-radar-hospitals\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#How_We_Selected_These_Under-the-Radar_Hospitals_Stocks\" title=\"How We Selected These Under-the-Radar Hospitals Stocks\">How We Selected These Under-the-Radar Hospitals Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#What_Are_Under_the_Radar_Hospital_Stocks_in_India\" title=\"What Are Under the Radar Hospital Stocks in India?\">What Are Under the Radar Hospital Stocks in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#5_Hospitals_Stocks_Flying_Under_the_Radar_in_India\" title=\"5 Hospitals Stocks Flying Under the Radar in India\">5 Hospitals Stocks Flying Under the Radar in India<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#1_HCG_Oncology_Healthcare_Global_HCGONCOL_Relatively_Under-Followed_Compared_With_Sector_Leaders\" title=\"1. HCG Oncology (Healthcare Global) (HCGONCOL): Relatively Under-Followed Compared With Sector Leaders\">1. HCG Oncology (Healthcare Global) (HCGONCOL): Relatively Under-Followed Compared With Sector Leaders<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Key_Metrics_to_Note\" title=\"Key Metrics to Note\">Key Metrics to Note<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Why_It_Receives_Comparatively_Lower_Coverage\" title=\"Why It Receives Comparatively Lower Coverage\">Why It Receives Comparatively Lower Coverage<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Key_Risk\" title=\"Key Risk\">Key Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#2_Care_Hospitals_CAREHOSPITAL_Relatively_Under-Followed_Compared_With_Sector_Leaders\" title=\"2. Care Hospitals (CAREHOSPITAL): Relatively Under-Followed Compared With Sector Leaders\">2. Care Hospitals (CAREHOSPITAL): Relatively Under-Followed Compared With Sector Leaders<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Key_Metrics_to_Note-2\" title=\"Key Metrics to Note\">Key Metrics to Note<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Why_It_Receives_Comparatively_Lower_Coverage-2\" title=\"Why It Receives Comparatively Lower Coverage\">Why It Receives Comparatively Lower Coverage<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Key_Risk-2\" title=\"Key Risk\">Key Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#3_Fortis_Healthcare_FORTIS_Relatively_Under-Followed_Compared_With_Sector_Leaders\" title=\"3. Fortis Healthcare (FORTIS): Relatively Under-Followed Compared With Sector Leaders\">3. Fortis Healthcare (FORTIS): Relatively Under-Followed Compared With Sector Leaders<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Key_Metrics_to_Note-3\" title=\"Key Metrics to Note\">Key Metrics to Note<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Why_It_Receives_Comparatively_Lower_Coverage-3\" title=\"Why It Receives Comparatively Lower Coverage\">Why It Receives Comparatively Lower Coverage<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Key_Risk-3\" title=\"Key Risk\">Key Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#4_Global_Health_Medanta_MEDANTA_Relatively_Under-Followed_Compared_With_Sector_Leaders\" title=\"4. Global Health (Medanta) (MEDANTA): Relatively Under-Followed Compared With Sector Leaders\">4. Global Health (Medanta) (MEDANTA): Relatively Under-Followed Compared With Sector Leaders<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Key_Metrics_to_Note-4\" title=\"Key Metrics to Note\">Key Metrics to Note<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Why_It_Receives_Comparatively_Lower_Coverage-4\" title=\"Why It Receives Comparatively Lower Coverage\">Why It Receives Comparatively Lower Coverage<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Key_Risk-4\" title=\"Key Risk\">Key Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#5_Narayana_Hrudayalaya_NH_ROE_of_220_Relatively_Lower_Institutional_Attention\" title=\"5. Narayana Hrudayalaya (NH): ROE of 22.0%, Relatively Lower Institutional Attention\">5. Narayana Hrudayalaya (NH): ROE of 22.0%, Relatively Lower Institutional Attention<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Key_Metrics_to_Note-5\" title=\"Key Metrics to Note\">Key Metrics to Note<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Why_It_Receives_Comparatively_Lower_Coverage-5\" title=\"Why It Receives Comparatively Lower Coverage\">Why It Receives Comparatively Lower Coverage<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Key_Risk-5\" title=\"Key Risk\">Key Risk<\/a><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Quick_Comparison_5_Under-the-Radar_Stocks_at_a_Glance\" title=\"Quick Comparison: 5 Under-the-Radar Stocks at a Glance\">Quick Comparison: 5 Under-the-Radar Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Why_Do_These_Hospitals_Stocks_Receive_Comparatively_Lower_Coverage\" title=\"Why Do These Hospitals Stocks Receive Comparatively Lower Coverage?\">Why Do These Hospitals Stocks Receive Comparatively Lower Coverage?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#What_Factors_Should_Investors_Evaluate_in_Hospital_Lesser-Known_Hospitals_Stocks\" title=\"What Factors Should Investors Evaluate in Hospital Lesser-Known Hospitals Stocks?\">What Factors Should Investors Evaluate in Hospital Lesser-Known Hospitals Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Key_Risks_to_Evaluate_in_Under-the-Radar_Hospitals_Stocks\" title=\"Key Risks to Evaluate in Under-the-Radar Hospitals Stocks\">Key Risks to Evaluate in Under-the-Radar Hospitals Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#How_to_Research_and_Invest_in_Hospital_Stocks_in_India\" title=\"How to Research and Invest in Hospital Stocks in India\">How to Research and Invest in Hospital Stocks in India<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Key_Takeaways_on_Hospital_Stocks\" title=\"Key Takeaways on Hospital Stocks\">Key Takeaways on Hospital Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Frequently_Asked_Questions_on_Under_the_Radar_Hospital_Stocks\" title=\"Frequently Asked Questions on Under the Radar Hospital Stocks\">Frequently Asked Questions on Under the Radar Hospital Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Which_hospital_stocks_are_flying_under_the_radar_in_India\" title=\"Which hospital stocks are flying under the radar in India?\">Which hospital stocks are flying under the radar in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Are_smallcap_hospital_stocks_suitable_for_long-term_investment\" title=\"Are smallcap hospital stocks suitable for long-term investment?\">Are smallcap hospital stocks suitable for long-term investment?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-34\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#What_are_the_key_metrics_to_check_in_hospital_stocks\" title=\"What are the key metrics to check in hospital stocks?\">What are the key metrics to check in hospital stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-35\" href=\"https:\/\/univest.in\/blogs-2\/hospitals-stocks-flying-under-the-radar-india\/#Is_HCG_Oncology_Healthcare_Global_a_good_stock_to_research\" title=\"Is HCG Oncology (Healthcare Global) a good stock to research?\">Is HCG Oncology (Healthcare Global) a good stock to research?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2 id=\"methodology\"><span class=\"ez-toc-section\" id=\"How_We_Selected_These_Under-the-Radar_Hospitals_Stocks\"><\/span><strong>How We Selected These Under-the-Radar Hospitals Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The five companies below were selected on the following basis:<\/p>\n<ul>\n<li><strong>Sector relevance:<\/strong> Each company operates meaningfully in the hospital sector with an established business presence.<\/li>\n<li><strong>Market capitalisation:<\/strong> The list focuses on smallcap and midcap companies. However, market cap alone is not the definition of &#8220;under the radar&#8221;. Several mid-cap companies receive extensive coverage while smaller ones do not.<\/li>\n<li><strong>Institutional coverage and visibility:<\/strong> &#8220;Under the radar&#8221; refers to comparatively lower analyst coverage, media attention, and investor awareness relative to the sector&#8217;s largest and most widely followed names. This is a qualitative assessment based on general market observation.<\/li>\n<li><strong>Financial characteristics:<\/strong> Each company shows at least one financial characteristic worth evaluating, such as a notable ROE, low leverage, or a specific PE profile relative to its business stage.<\/li>\n<\/ul>\n<p><strong>Data note:<\/strong> All market data , CMP, market cap, PE, ROE, D\/E, and 52-week range , is based on publicly available NSE and BSE data as of 23 August 2026. Investors should verify all figures before making any decision. This selection is for educational and research purposes only.<\/p>\n<h2 id=\"what-are\"><span class=\"ez-toc-section\" id=\"What_Are_Under_the_Radar_Hospital_Stocks_in_India\"><\/span><strong>What Are Under the Radar Hospital Stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Hospital stocks are smallcap and midcap companies operating in the hospital sector that are not among the most-followed names tracked by large institutional brokerages. These hospital stocks may have solid fundamentals but receive fewer dedicated research notes, consensus price targets, or media coverage than their larger peers.<\/p>\n<p>Identifying hospital stocks requires scanning beyond the top ten holdings of major hospital sector mutual funds and ETFs. Companies that become hospital stocks on institutional radars often do so because their size falls below the minimum threshold that large portfolio managers can deploy capital into. This structural gap, not necessarily a business quality gap, is why these hospital stocks remain under the radar.<\/p>\n<h2 id=\"five-stocks\"><span class=\"ez-toc-section\" id=\"5_Hospitals_Stocks_Flying_Under_the_Radar_in_India\"><\/span><strong>5 Hospitals Stocks Flying Under the Radar in India<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The five hospital stocks below were selected as worth placing on a research watchlist, not as definitive buy recommendations. Each hospital stocks has a different risk-return profile and should be evaluated independently against an investor&#8217;s own criteria and risk appetite.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px;\">\n<thead>\n<tr>\n<th style=\"background: #1F4E79; color: #fff; padding: 10px 12px; text-align: left;\">Company<\/th>\n<th style=\"background: #1F4E79; color: #fff; padding: 10px 12px; text-align: right;\">NSE Symbol<\/th>\n<th style=\"background: #1F4E79; color: #fff; padding: 10px 12px; text-align: right;\">CMP (Rs)<\/th>\n<th style=\"background: #1F4E79; color: #fff; padding: 10px 12px; text-align: right;\">MCap (Rs Cr)<\/th>\n<th style=\"background: #1F4E79; color: #fff; padding: 10px 12px; text-align: right;\">PE<\/th>\n<th style=\"background: #1F4E79; color: #fff; padding: 10px 12px; text-align: right;\">ROE<\/th>\n<th style=\"background: #1F4E79; color: #fff; padding: 10px 12px; text-align: right;\">D\/E<\/th>\n<th style=\"background: #1F4E79; color: #fff; padding: 10px 12px; text-align: right;\">52W Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px 12px;\">HCG Oncology (Healthcare Global)<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">HCGONCOL<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">335.0<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">3,550<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">50.00<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">10.00%<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">1.00<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">430.0 &#8211; 255.0<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px 12px;\">Care Hospitals<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">CAREHOSPITAL<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">656.0<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">16,200<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">45.00<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">15.00%<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">0.30<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">815.0 &#8211; 500.0<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px 12px;\">Fortis Healthcare<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">FORTIS<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">710.0<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">53,700<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">55.00<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">12.00%<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">0.20<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">880.0 &#8211; 545.0<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px 12px;\">Global Health (Medanta)<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">MEDANTA<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">1320.0<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">32,400<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">70.00<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">18.00%<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">0.10<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">1640.0 &#8211; 1010.0<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px 12px;\">Narayana Hrudayalaya<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">NH<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">1360.0<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">27,800<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">45.00<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">22.00%<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">0.15<\/td>\n<td style=\"padding: 10px 12px; text-align: right;\">1695.0 &#8211; 1055.0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"font-size: 12px; color: #666; margin-top: 6px;\"><em>Data as of 23 August 2026. Source: NSE\/BSE public disclosures. Verify before investing.<\/em><\/p>\n<h3><span class=\"ez-toc-section\" id=\"1_HCG_Oncology_Healthcare_Global_HCGONCOL_Relatively_Under-Followed_Compared_With_Sector_Leaders\"><\/span><strong>1. HCG Oncology (Healthcare Global) (HCGONCOL): Relatively Under-Followed Compared With Sector Leaders<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>HCG Oncology (Healthcare Global Enterprises) operates India&#8217;s largest oncology-focused hospital network, with 20+ cancer centres across Bengaluru, Ahmedabad, Kolkata, and international centres in East Africa. HCG Oncology (Healthcare Global) is one of the hospital stocks covered here, currently trading at Rs 335.0, with a market cap of Rs 3,550 crore and a 52-week range of Rs 255.0 to Rs 430.0. This hospital stocks is evaluated on publicly available NSE and BSE data.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Key_Metrics_to_Note\"><\/span><strong>Key Metrics to Note<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p>A PE of 50.00 is above the broader market average. At this level, the market is embedding expectations of continued earnings growth, making execution consistency an important factor to watch. ROE of 10.00% is below the 12-15% threshold many investors use as a quality filter. This warrants scrutiny of whether the business is in an investment phase or facing structural profitability constraints. D\/E of 1.00 reflects moderate leverage. Rising interest costs can weigh on net margins if not offset by revenue growth.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Why_It_Receives_Comparatively_Lower_Coverage\"><\/span><strong>Why It Receives Comparatively Lower Coverage<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p>HCG&#8217;s oncology specialisation gives it a first-mover advantage in a disease area with growing prevalence and significant under-treatment. Cancer treatment typically requires multi-cycle visits over months, creating recurring patient revenue per admission that general hospitals cannot replicate through single-episode treatments.<\/p>\n<p>As a hospital stocks, HCG Oncology (Healthcare Global) sits in a segment of the hospital sector where dedicated research is less common than among the largest-cap peers. Investors tracking hospital stocks should add this company to their research watchlist only after verifying data on NSE or BSE.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Key_Risk\"><\/span><strong>Key Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p><strong>Key Risk for this hospital stocks:<\/strong> Cancer treatment centres have long capital payback periods because clinical reputation must be established before patient volumes reach optimal utilisation. D\/E of 1.0 reflects this capital intensity, and any slowdown in new centre ramp-up extends the payback on invested capital. Cross-verify risks among all hospital stocks before drawing conclusions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Care_Hospitals_CAREHOSPITAL_Relatively_Under-Followed_Compared_With_Sector_Leaders\"><\/span><strong>2. Care Hospitals (CAREHOSPITAL): Relatively Under-Followed Compared With Sector Leaders<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Care Hospitals is a multi-speciality hospital chain backed by Blackstone, operating 17 hospitals across Hyderabad, Bhopal, Nagpur, Visakhapatnam, and other cities with a focus on secondary and tertiary care in tier-I and tier-II India. Care Hospitals is one of the hospital stocks covered here, currently trading at Rs 656.0, with a market cap of Rs 16,200 crore and a 52-week range of Rs 500.0 to Rs 815.0. This hospital stocks is evaluated on publicly available NSE and BSE data.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Key_Metrics_to_Note-2\"><\/span><strong>Key Metrics to Note<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p>A PE of 45.00 is above the broader market average. At this level, the market is embedding expectations of continued earnings growth, making execution consistency an important factor to watch. ROE of 15.00% sits at a reasonable level. Tracking whether this has been improving or declining over recent quarters provides a more complete picture. D\/E of 0.30 reflects low leverage, providing financial flexibility in varied interest-rate environments.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Why_It_Receives_Comparatively_Lower_Coverage-2\"><\/span><strong>Why It Receives Comparatively Lower Coverage<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p>Blackstone&#8217;s institutional ownership provides a professional management layer and capital access that distinguishes Care from promoter-run hospital chains. Its geographic spread across central and south India captures markets where quality multi-speciality care is still underpenetrated relative to population.<\/p>\n<p>As a hospital stocks, Care Hospitals sits in a segment of the hospital sector where dedicated research is less common than among the largest-cap peers. Investors tracking hospital stocks should add this company to their research watchlist only after verifying data on NSE or BSE.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Key_Risk-2\"><\/span><strong>Key Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p><strong>Key Risk for this hospital stocks:<\/strong> Blackstone&#8217;s eventual exit from the investment will require a secondary offering or IPO of additional shares at some point, creating overhang risk for existing public shareholders. The hospital scale-up phase requires ongoing capex across all 17 facilities simultaneously. Cross-verify risks among all hospital stocks before drawing conclusions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Fortis_Healthcare_FORTIS_Relatively_Under-Followed_Compared_With_Sector_Leaders\"><\/span><strong>3. Fortis Healthcare (FORTIS): Relatively Under-Followed Compared With Sector Leaders<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Fortis Healthcare is one of India&#8217;s largest hospital chains, operating 35+ hospitals across 10 cities under the Fortis and La Femme brands, with a diagnostics arm (SRL Diagnostics) providing integrated hospital-diagnostics synergies. Fortis Healthcare is one of the hospital stocks covered here, currently trading at Rs 710.0, with a market cap of Rs 53,700 crore and a 52-week range of Rs 545.0 to Rs 880.0. This hospital stocks is evaluated on publicly available NSE and BSE data.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Key_Metrics_to_Note-3\"><\/span><strong>Key Metrics to Note<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p>A PE of 55.00 is above the broader market average. At this level, the market is embedding expectations of continued earnings growth, making execution consistency an important factor to watch. ROE of 12.00% sits at a reasonable level. Tracking whether this has been improving or declining over recent quarters provides a more complete picture. D\/E of 0.20 reflects low leverage, providing financial flexibility in varied interest-rate environments.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Why_It_Receives_Comparatively_Lower_Coverage-3\"><\/span><strong>Why It Receives Comparatively Lower Coverage<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p>Fortis&#8217;s scale of 35+ hospitals gives it negotiating leverage with medical equipment suppliers, pharmaceutical companies, and health insurance providers that smaller chains cannot access. Its international patient revenue from Middle East and South Asian medical tourists provides a premium revenue segment alongside domestic patients.<\/p>\n<p>As a hospital stocks, Fortis Healthcare sits in a segment of the hospital sector where dedicated research is less common than among the largest-cap peers. Investors tracking hospital stocks should add this company to their research watchlist only after verifying data on NSE or BSE.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Key_Risk-3\"><\/span><strong>Key Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p><strong>Key Risk for this hospital stocks:<\/strong> Fortis has had a complex ownership history with governance controversies that created significant institutional investor concerns. While the current management under IHH Healthcare&#8217;s backing has stabilised operations, the historical overhang continues to affect some long-term investor appetite. Cross-verify risks among all hospital stocks before drawing conclusions.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Use the Univest Screener to Compare Live Hospitals Stocks by PE, ROE and Debt<\/strong><\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Global_Health_Medanta_MEDANTA_Relatively_Under-Followed_Compared_With_Sector_Leaders\"><\/span><strong>4. Global Health (Medanta) (MEDANTA): Relatively Under-Followed Compared With Sector Leaders<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Global Health (Medanta) operates the Medanta brand of super-speciality hospitals, including the flagship Gurugram hospital and newer facilities in Lucknow, Patna, Ranchi, and Indore, with a physician-owned model emphasising clinical excellence. Global Health (Medanta) is one of the hospital stocks covered here, currently trading at Rs 1320.0, with a market cap of Rs 32,400 crore and a 52-week range of Rs 1010.0 to Rs 1640.0. This hospital stocks is evaluated on publicly available NSE and BSE data.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Key_Metrics_to_Note-4\"><\/span><strong>Key Metrics to Note<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p>A PE of 70.00 reflects a growth-priced valuation where significant future earnings expansion is already factored in. Any earnings miss against this expectation tends to have an amplified share-price impact. ROE of 18.00% sits at a reasonable level. Tracking whether this has been improving or declining over recent quarters provides a more complete picture. D\/E of 0.10 reflects low leverage, providing financial flexibility in varied interest-rate environments.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Why_It_Receives_Comparatively_Lower_Coverage-4\"><\/span><strong>Why It Receives Comparatively Lower Coverage<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p>Medanta&#8217;s physician-ownership model and super-speciality focus drives ARPOB (Average Revenue Per Occupied Bed) significantly above industry averages. Its Gurugram flagship hospital attracts a disproportionate share of high-acuity patients from north India and international medical tourists.<\/p>\n<p>As a hospital stocks, Global Health (Medanta) sits in a segment of the hospital sector where dedicated research is less common than among the largest-cap peers. Investors tracking hospital stocks should add this company to their research watchlist only after verifying data on NSE or BSE.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Key_Risk-4\"><\/span><strong>Key Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p><strong>Key Risk for this hospital stocks:<\/strong> At PE 70, Medanta is priced as a premium hospital chain and new hospital ramp-ups carry meaningful execution risk. The Lucknow, Patna, and Ranchi hospitals are still in their early occupancy ramp-up phases, meaning capital is fully deployed ahead of optimal revenue generation. Cross-verify risks among all hospital stocks before drawing conclusions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Narayana_Hrudayalaya_NH_ROE_of_220_Relatively_Lower_Institutional_Attention\"><\/span><strong>5. Narayana Hrudayalaya (NH): ROE of 22.0%, Relatively Lower Institutional Attention<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Narayana Hrudayalaya is a multi-speciality hospital chain founded by cardiac surgeon Dr Devi Shetty, operating 21+ hospitals across India and in the Cayman Islands, with a mission-driven low-cost cardiac surgery model that has treated over 5 million patients. Narayana Hrudayalaya is one of the hospital stocks covered here, currently trading at Rs 1360.0, with a market cap of Rs 27,800 crore and a 52-week range of Rs 1055.0 to Rs 1695.0. This hospital stocks is evaluated on publicly available NSE and BSE data.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Key_Metrics_to_Note-5\"><\/span><strong>Key Metrics to Note<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p>A PE of 45.00 is above the broader market average. At this level, the market is embedding expectations of continued earnings growth, making execution consistency an important factor to watch. ROE of 22.00% is above-average for most sectors, suggesting the business generates meaningful returns on the equity base deployed. D\/E of 0.15 reflects low leverage, providing financial flexibility in varied interest-rate environments.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Why_It_Receives_Comparatively_Lower_Coverage-5\"><\/span><strong>Why It Receives Comparatively Lower Coverage<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p>NH&#8217;s ROE of 22% is the strongest of the listed hospital chains, reflecting a genuinely efficient operating model where high surgical volumes reduce per-surgery cost and allow affordable pricing. Its Cayman Islands Facilities Hospital serves international medical tourists with premium pricing that cross-subsidises its Indian low-cost model.<\/p>\n<p>As a hospital stocks, Narayana Hrudayalaya sits in a segment of the hospital sector where dedicated research is less common than among the largest-cap peers. Investors tracking hospital stocks should add this company to their research watchlist only after verifying data on NSE or BSE.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Key_Risk-5\"><\/span><strong>Key Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p><strong>Key Risk for this hospital stocks:<\/strong> Narayana&#8217;s affordable cardiac surgery model operates on volume economics that require consistent throughput. Any slowdown in surgical volumes due to competitive pressure from newer cardiac centres or a broader economic contraction affecting patient footfall can quickly compress margins given the fixed cost structure. Cross-verify risks among all hospital stocks before drawing conclusions.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track live hospitals prices and get daily research.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Quick_Comparison_5_Under-the-Radar_Stocks_at_a_Glance\"><\/span><strong>Quick Comparison: 5 Under-the-Radar Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below summarises each company&#8217;s standout attribute and primary risk for quick reference. This is a research shortlist, not a ranking.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 13px;\">\n<thead>\n<tr>\n<th style=\"background: #1F4E79; color: #fff; padding: 8px 10px; text-align: left;\">Stock<\/th>\n<th style=\"background: #1F4E79; color: #fff; padding: 8px 10px; text-align: left;\">Standout Attribute<\/th>\n<th style=\"background: #1F4E79; color: #fff; padding: 8px 10px; text-align: left;\">Key Metrics<\/th>\n<th style=\"background: #1F4E79; color: #fff; padding: 8px 10px; text-align: left;\">Primary Risk<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 8px 10px;\">HCG Oncology (Healthcare Global)<\/td>\n<td style=\"padding: 8px 10px;\">MCap Rs 3,550 Cr, lower coverage<\/td>\n<td style=\"padding: 8px 10px;\">PE 50.0, ROE 10.0%, D\/E 1.00<\/td>\n<td style=\"padding: 8px 10px;\">Cancer treatment centres have long capital payback periods because clinical reputation must be established before patient volumes reach optimal utilisation.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 10px;\">Care Hospitals<\/td>\n<td style=\"padding: 8px 10px;\">MCap Rs 16,200 Cr, lower coverage<\/td>\n<td style=\"padding: 8px 10px;\">PE 45.0, ROE 15.0%, D\/E 0.30<\/td>\n<td style=\"padding: 8px 10px;\">Blackstone&#8217;s eventual exit from the investment will require a secondary offering or IPO of additional shares at some point, creating overhang risk for existing public shareholders.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 10px;\">Fortis Healthcare<\/td>\n<td style=\"padding: 8px 10px;\">MCap Rs 53,700 Cr, lower coverage<\/td>\n<td style=\"padding: 8px 10px;\">PE 55.0, ROE 12.0%, D\/E 0.20<\/td>\n<td style=\"padding: 8px 10px;\">Fortis has had a complex ownership history with governance controversies that created significant institutional investor concerns.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 10px;\">Global Health (Medanta)<\/td>\n<td style=\"padding: 8px 10px;\">MCap Rs 32,400 Cr, lower coverage<\/td>\n<td style=\"padding: 8px 10px;\">PE 70.0, ROE 18.0%, D\/E 0.10<\/td>\n<td style=\"padding: 8px 10px;\">At PE 70, Medanta is priced as a premium hospital chain and new hospital ramp-ups carry meaningful execution risk.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 10px;\">Narayana Hrudayalaya<\/td>\n<td style=\"padding: 8px 10px;\">22.0% ROE<\/td>\n<td style=\"padding: 8px 10px;\">PE 45.0, ROE 22.0%, D\/E 0.15<\/td>\n<td style=\"padding: 8px 10px;\">Narayana&#8217;s affordable cardiac surgery model operates on volume economics that require consistent throughput.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 id=\"why-radar\"><span class=\"ez-toc-section\" id=\"Why_Do_These_Hospitals_Stocks_Receive_Comparatively_Lower_Coverage\"><\/span><strong>Why Do These Hospitals Stocks Receive Comparatively Lower Coverage?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Lower trading volumes further reduce interest from momentum traders, keeping news flow consistently thin. Historically, some of India&#8217;s strongest multi-year compounding has originated from exactly this kind of overlooked ground , when a cycle shift or earnings re-rating forces the broader market to reassess what the fundamentals already indicated. That said, low coverage is neither a guarantee of outperformance nor a signal of undervaluation on its own.<\/p>\n<h2 id=\"factors\"><span class=\"ez-toc-section\" id=\"What_Factors_Should_Investors_Evaluate_in_Hospital_Lesser-Known_Hospitals_Stocks\"><\/span><strong>What Factors Should Investors Evaluate in Hospital Lesser-Known Hospitals Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Return on equity:<\/strong> Look for ROE consistently above 12-15% across multiple reporting periods, not just peak-cycle years. High and consistent ROE signals capital efficiency that PE screens alone cannot capture.<\/li>\n<li><strong>Debt-to-equity ratio:<\/strong> Low D\/E provides operational runway to survive a difficult year without equity dilution or asset sales. A D\/E below 0.30 is generally considered low leverage for non-financial companies.<\/li>\n<li><strong>PE relative to sector PE:<\/strong> A discount to sector PE is only meaningful if business quality supports the comparison. Always check the current sector PE on NSE or BSE and pair this with ROE and D\/E data.<\/li>\n<li><strong>Revenue and profit growth:<\/strong> Consistent revenue growth over three to five years is more meaningful than a single strong year. Check the quarterly results section on NSE (nseindia.com) for the complete trend.<\/li>\n<li><strong>Promoter holding:<\/strong> Stable or increasing promoter holding often signals confidence in the business outlook. Significant promoter selling should prompt additional scrutiny. Check the latest shareholding disclosure on NSE or BSE before investing.<\/li>\n<li><strong>Consistency over multiple years:<\/strong> A single exceptional year of high ROE or low D\/E can be misleading. Look for patterns across 3-5 years of annual reports. Companies with consistent financial characteristics tend to be structurally sound rather than cyclically lucky. Annual reports are available on the respective company investor relations pages and on NSE and BSE.<\/li>\n<\/ul>\n<h2 id=\"risks\"><span class=\"ez-toc-section\" id=\"Key_Risks_to_Evaluate_in_Under-the-Radar_Hospitals_Stocks\"><\/span><strong>Key Risks to Evaluate in Under-the-Radar Hospitals Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Valuation compression:<\/strong> Several stocks on this list carry PE multiples above 40x, embedding growth expectations that require consistent execution. Any earnings miss against these expectations can cause disproportionate share-price corrections.<\/li>\n<li><strong>Low trading liquidity:<\/strong> Smallcap hospitals stocks can move sharply on modest volumes. Building or exiting a large position without meaningful market impact can be challenging in lower-volume names.<\/li>\n<li><strong>Input-cost inflation:<\/strong> Many hospitals companies face raw material cost volatility. A sudden spike in input prices without the pricing power to pass through costs can rapidly compress margins.<\/li>\n<li><strong>Earnings cyclicality:<\/strong> Smallcap companies tend to deliver less stable quarter-on-quarter earnings growth than large caps. Investors must be prepared for wider swings in reported profits, sometimes within the same financial year.<\/li>\n<li><strong>Competitive intensity:<\/strong> Larger sector players with established distribution, brand recall, and balance-sheet strength can pressure smaller companies&#8217; market share in a downturn.<\/li>\n<\/ul>\n<h2 id=\"how-to\"><span class=\"ez-toc-section\" id=\"How_to_Research_and_Invest_in_Hospital_Stocks_in_India\"><\/span><strong>How to Research and Invest in Hospital Stocks in India<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Start with the business model. Each of the five companies on this list operates differently, and position sizing should reflect the specific risk-return profile of each rather than treating them as a uniform group.<\/p>\n<p>Verify independently. All figures in this article are based on publicly available NSE and BSE data as of 23 August 2026. Always check the latest quarterly results, annual reports, and shareholding disclosures on nseindia.com or bseindia.com before investing.<\/p>\n<p>Use a screener to compare. The Univest Screener allows investors to apply PE, ROE, and D\/E filters on live market data to build a comparison shortlist across the hospitals sector.<\/p>\n<p>Diversify across names where relevant. Concentrating entirely in one smallcap hospital stocks amplifies single-stock event risk. Spreading exposure across two or three names where the thesis is independently sound reduces that risk meaningfully. Consult a SEBI-registered investment advisor to align any investment with your personal financial goals.<\/p>\n<p>Track earnings trends, not just a point-in-time snapshot. The metrics shown in this article reflect data as of 23 August 2026. These figures will change with each quarterly result. Building a simple trend view across three to five recent quarters tells you far more about business direction than any single set of current figures. NSE&#8217;s quarterly results archive is a free, comprehensive primary source for this data. Combine it with the company&#8217;s own investor presentations where available.<\/p>\n<h2 id=\"takeaways\"><span class=\"ez-toc-section\" id=\"Key_Takeaways_on_Hospital_Stocks\"><\/span><strong>Key Takeaways on Hospital Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The five hospital stocks covered here represent a range of market caps and business models within the hospital sector.<\/li>\n<li>Each of these hospital stocks has been selected based on publicly available fundamental data as of 23 August 2026.<\/li>\n<li>Investors researching hospital stocks should verify all figures on NSE or BSE directly before making any decision.<\/li>\n<li>The hospital sector has more depth than the top three names. These hospital stocks are the starting point for broader exploration.<\/li>\n<li>No hospital stocks selection is permanent. Review the thesis quarterly as new fundamental data becomes available.<\/li>\n<\/ul>\n<h2 id=\"conclusion\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The five hospital stocks companies covered in this article , HCG Oncology (Healthcare Global) (PE 50.0), Care Hospitals (PE 45.0), Fortis Healthcare (PE 55.0), Global Health (Medanta) (D\/E 0.10), and Narayana Hrudayalaya (ROE 22.0%) , each present a distinct profile. They are not identical in their risk-return characteristics, their stage of development, or the reason they receive comparatively lower institutional attention. Investors researching hospital stocks in India should evaluate each company independently using its own financial history, management track record, and position within the sector before drawing any conclusion.<\/p>\n<p>None of the companies in this article are presented as buy recommendations. The hospital sector carries market, operational, and valuation risks that affect each of these five companies differently. Please consult a SEBI-registered investment advisor before making any investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available NSE and BSE information. These may or may not be accurate. Please verify all data with NSE (nseindia.com) and BSE (bseindia.com) before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 id=\"faqs\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Under_the_Radar_Hospital_Stocks\"><\/span><strong>Frequently Asked Questions on Under the Radar Hospital Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_hospital_stocks_are_flying_under_the_radar_in_India\"><\/span><strong>Which hospital stocks are flying under the radar in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Five hospital stocks that receive comparatively lower institutional coverage in India are HCG Oncology (Healthcare Global), Care Hospitals, Fortis Healthcare, Global Health (Medanta), and Narayana Hrudayalaya. Each has a different fundamental profile. Treating these hospital stocks as research starting points, not buy signals, is advisable. Verify all data on NSE or BSE before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_smallcap_hospital_stocks_suitable_for_long-term_investment\"><\/span><strong>Are smallcap hospital stocks suitable for long-term investment?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Smallcap hospital stocks can offer higher potential returns than large-cap peers in a favourable cycle, but they also carry greater risks: lower liquidity, limited analyst coverage, and higher earnings volatility. Each of the five stocks covered here should be evaluated on its own financial merits and risk profile. Consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_metrics_to_check_in_hospital_stocks\"><\/span><strong>What are the key metrics to check in hospital stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key metrics include PE ratio (compared against the current sector PE on NSE or BSE), ROE (ideally above 12-15% consistently), D\/E ratio (lower is generally safer for non-financial companies), revenue growth trend, and promoter holding. No single metric should be used in isolation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_HCG_Oncology_Healthcare_Global_a_good_stock_to_research\"><\/span><strong>Is HCG Oncology (Healthcare Global) a good stock to research?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> HCG Oncology (Healthcare Global) has a PE of 50.00 and an ROE of 10.00%, with a D\/E of 1.00 and a 52-week range of Rs 255.0 to Rs 430.0. These metrics are worth evaluating against the sector average and the company&#8217;s own historical performance. Verify all data on NSE before investing.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Explore 5 under the radar hospitals stocks in India with key PE, ROE, and debt metrics investors should evaluate. Covers HCG Oncology (Healthcare Global), Care Hospitals, Fortis Healthcare, and two more.<\/p>\n","protected":false},"author":35,"featured_media":217178,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[3802],"class_list":["post-217179","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["217178"],"_edit_lock":["1787564422:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["61"],"rank_math_title":["5 Under the Radar Hospitals Stocks in India 2026"],"rank_math_description":["Explore 5 under the radar hospital stocks in India, with key PE, ROE, debt, and business factors investors should evaluate. Covers HCG Oncology (Healthcare Global), Care"],"rank_math_focus_keyword":["5 Under the Radar Hospitals"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["39571"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/hospitals-stocks-flying-under-the-radar-india.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/217179","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=217179"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/217179\/revisions"}],"predecessor-version":[{"id":217208,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/217179\/revisions\/217208"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/217178"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=217179"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=217179"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=217179"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}